4.1 Article

Ossifying Fibroma: Analysis of Treatment Methods and Recurrence Patterns

期刊

JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY
卷 74, 期 12, 页码 2409-2419

出版社

W B SAUNDERS CO-ELSEVIER INC
DOI: 10.1016/j.joms.2016.05.018

关键词

-

资金

  1. DAAD foundation (German Academic Exchange Service)
  2. National Research Foundation of South Africa

向作者/读者索取更多资源

Purpose: Ossifying fibroma (OF) is one of the most frequent of the 3 fibro-osseous lesions of the jaws and has had an inconstant recurrence rate. A definitive surgical protocol has not yet been published. The aim of the present study was to determine the clinical and radiologic features of OF at a tertiary hospital in South Africa, assess its management and recurrence patterns, and develop a surgical protocol. Materials and Methods: A retrospective case-series analysis was performed of all histopathologically diagnosed OF cases from 1976 to 2014. The demographic data, clinical presentation, and radiographic features were analyzed. The management of each case and follow-up data were also documented. A surgical protocol was developed using these findings. Results: A total of 61 cases were included in the present study. Most of the patients were female (63.9%) and younger than 40 years old (73.9%), and only few cases were symptomatic (29.5%). The mandibular posterior region was affected most often (55.5%), and most lesions were radiopaque (49.2%) and had well-defined margins (93.6%). Most cases were managed by surgical curettage (68.2%). After an average follow-up period of 20 months, only 1 case had recurred for a recurrence rate of 6.7%. Conclusions: The lesions in our population were more radiopaque and larger than those in the published data. Surgical curettage is an acceptable management protocol with a low rate of recurrence, and resection should be reserved for aggressive and recurrent lesions. (C) 2016 American Association of Oral and Maxillofacial Surgeons

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.1
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据